We are monitoring the impact of COVID-19 on North America Genetic Testing Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 21
Share on
Share on

North America Genetic Testing Market Research Report - Segmented By Type (Carrier Testing, Diagnostic Testing, Prenatal Testing And Neonatal Testing), By Application (Cancer Testing, Pharmacogenomics Testing, Prenatal Testing And Predisposition Testing), And By Country (the US and Canada) - Size, Share, Growth, Trends, And Forecast (2019-2024)

Pulished: August, 2019
ID: 21
Pages: 138

North America Genetic Testing Market Size & Growth (2019 - 2024)

The size of the Genetic Testing Market in North America was valued at USD 17.24 million in 2019 and is forecasted to be a USD 29.74 Million by 2024 growing at a CAGR of 11.52% during the forecast period 2019-2024.

Currently, among the different segments of the molecular diagnostics market, genetic testing is most likely to be a highly attractive segment owing to the increasing need for superior healthcare. Genetic testing is a highly sophisticated form of testing where even a slight modification in DNA that is associated with any disease condition can be detected.

Genetic testing is the study of genes, chromosomes, or proteins that help to identify the diseases, carriers of a disease, diagnose diseases, or to determine the course of the disease. The evolution of genetic testing has enabled for easy diagnosis of diseases, like sickle cell anemia, hemophilia, and cystic fibrosis, thus helping many patients to lead a normal life.

An increase in awareness among the individuals about the benefits and the potentiality of genetic testing to identify and cure diseases or abnormalities is the main reason for the genetic testing market to grow. In addition, an increase in the aging population, advancements of technology in the genetic testing space, subsequent increase in the cases of chronic diseases, and rising cancer case incidences are the few other factors aiding the growth of the genetic testing market in North America.

However, factors like huge costs that are associated with genetic testing and the lack of standard procedures concerning the authenticity of genetic reports are hindering the growth of the North American genetic testing market.

With the growing genetic disease incidences, it unravels new opportunities for genetic testing and its related applications. The transformation of genetic testing from being a service-driven market to a product-driven market is anticipated to provide a push to the diagnostic companies for the expansion of their operations.

This report has been segmented and sub-segmented into the following categories.

  • By Application: Cancer Testing, Pharmacogenomics testing, Prenatal testing, and Predisposition testing.
  • By Test: Carrier Testing, Diagnostic Testing, Prenatal Testing, and Neonatal Testing.
  • By Country: the US and Canada.

Genetic testing in cancer is expected to dominate the market and is likely to witness high growth in the near future. The market for rare and fatal disorders diagnosing, screening of new-borns, and the probability estimation of disease occurrence is likely to expand. Particularly, tests for screening the new-borns are likely to expand enormously over the coming years.

Regionally, the US represents the largest market for genetic testing worldwide. Screening for genetic mutations within the CFTR (Cystic Fibrosis Trans-Membrane Conductance Regulator) gene is the most recurrently conducted test in the US.

Major players operating in the North American Genetic Testing Market profiled in this report are Abbott Laboratories, Roche Molecular Diagnostics Inc., Abbott Molecular Inc., AutoGenomics Inc., Celera Group, ELITech Group, BioRad Laboratories, PerkinElmer Inc., Roche Diagnostics Corp., Quest Diagnostics Inc., Transgenomic Inc. and Applied Biosystems Inc.,

This report helps you in:

  • Current and future North America Genetic Testing Market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • Identifying the segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Type        

                                5.1.1 Carrier Testing

                                5.1.2 Diagnostic Testing

                                5.1.3 Prenatal Testing

                                5.1.4 Neonatal Testing

                5.2 By Application           

                                5.2.1 Cancer Testing

                                5.2.2 Prenatal Testing

                                5.2.3 Pharmacogenomics Testing

                                5.2.4 Presdisposition Testing

6. Geographical Analysis                              

                6.1 Introduction              

                6.2 United States            

                6.3 Canada         

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Roche Molecular Diagnostics Inc.      

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Abbott Laboratories

                8.3 AutoGenomics Inc. 

                8.4 Celera Group             

                8.5 ELITech Group          

                8.6 BioRad Laboratories

                8.7 Quest Diagnostics Inc             

                8.8 Transgenomic Inc.   

                8.9 Applied Biosystems Inc.,       

                8.10 PerkinElmer Inc      

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Expert Opinions                         

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Genetic Testing Market By Region, From 2018-2023 ( USD Million )
  2. North America Genetic Testing Market By Type, From 2018-2023 ( USD Million )
  3. North America Carrier Testing Market By Region, From 2018-2023 ( USD Million )
  4. North America Diagnostic Testing Market By Region, From 2018-2023 ( USD Million )
  5. North America Prenatal Testing Market By Region, From 2018-2023 ( USD Million )
  6. North America Neonatal Testing Market By Region, From 2018-2023 ( USD Million )
  7. North America Genetic Testing Market By Application, From 2018-2023 ( USD Million )
  8. North America Cancer Testing Market By Region, From 2018-2023 ( USD Million )
  9. North America Prenatal Testing Market By Region, From 2018-2023 ( USD Million )
  10. North America Pharmacogenomics Testing Market By Region, From 2018-2023 ( USD Million )
  11. North America Predisposition Testing Market By Region, From 2018-2023 ( USD Million )
  12. United States Genetic Testing Market By Type, From 2018-2023 ( USD Million )
  13. United States Genetic Testing Market By Application, From 2018-2023 ( USD Million )
  14. Canada Genetic Testing Market By Type, From 2018-2023 ( USD Million )
  15. Canada Genetic Testing Market By Application, From 2018-2023 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample